DKSH Technology Signs Biomedic Acquisition in Vietnam 17.12.2025, 07:00 Uhr von EQS News Jetzt kommentieren: 0

Werte zum Artikel
Name Aktuell Diff. Börse
DKSH Holding 62,20 EUR +1,30 % Lang & Schwarz

DKSH Management Ltd. / Key word(s): Acquisition/Takeover
DKSH Technology Signs Biomedic Acquisition in Vietnam

17.12.2025 / 07:00 CET/CEST


Media Release

DKSH has signed an agreement to acquire Biomedic Science Material Joint Stock Company (“Biomedic”), a leading distributor of equipment and reagents used in the biotechnology and diagnostic market in Vietnam. With this transaction, DKSH Technology further extends its scientific solutions business in line with the Business Unit’s strategy to solidify its position as a leading scientific solutions provider in Asia and Beyond.

Zurich, Switzerland, December 17, 2025 – DKSH has signed an agreement to acquire Biomedic, a leading Vietnamese distributor of testing, diagnosis and screening solutions in oncology, obstetrics and gynecology, infectious diseases, and forensics.

Established in 2008, Biomedic is based in Hanoi, Vietnam, with over 80 employees across three locations in Vietnam. The company generates annual net sales of around CHF 12 million1 at good profitability. Leveraging long-standing relationships with renowned blue-chip clients, Biomedic serves a broad customer base in the Vietnamese healthcare industry, including prestigious hospitals, testing centers, and fertility support centers. Based on its equipment placement model, Biomedic generates a high share of revenues from recurring consumables.

Mr. Cao Tien Dung, Founder of Biomedic, said: “Over nearly two decades, we have established a strong track record of successfully connecting global biotechnology companies with our customer network across the Vietnamese market. The combination with DKSH marks the next leap in our growth trajectory. Our existing customer base will unlock growth opportunities for DKSH across Vietnam, while we can further scale our business through the Group’s strong sales channels. We are confident that this step will deliver meaningful benefits to both our business partners and our valued employees.”

Hanno Elbraechter, Head Business Unit Technology at DKSH, said: “We are delighted to join forces with Biomedic. Biomedic is known in the industry for its market-leading application and scientific workflow knowledge, as well as a strong team of sales, service and application specialists covering both northern and southern Vietnam. Biomedic will enable DKSH Technology to further build on its strong market position across the growing life science and healthcare space in Vietnam.”

The closing of the transaction is expected during the first quarter of 2026 and is subject to certain conditions.


1 1 Swiss franc equals 33’220 Vietnamese Dong.

About DKSH
For 160 years, DKSH has been delivering growth for companies in Asia and beyond across its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services, following its purpose of enriching people’s lives. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 28,060 specialists, generating net sales of CHF 11.1 billion in 2024. DKSH Business Unit Technology offers complete solutions for specialized scientific and industrial applications. With around 1,820 specialists, the Business Unit generated net sales of CHF 549 million in 2024. www.dksh.com/tec 

For further information, please contact:

 

DKSH Holding Ltd.

Till Leisner

Head, Investor & Media Relations, Sustainability

Phone +41 44 386 7315 

till.leisner@dksh.com
 

Melanie Grüter

Manager, Group Media Relations
Phone +41 44 386 7211 

melanie.grueter@dksh.com



End of Media Release
View original content: EQS News


Language: English
Company: DKSH Management Ltd.
Wiesenstrasse 8
8008 Zurich
Switzerland
Phone: 044 386 72 72
E-mail: media@dksh.com
Internet: www.dksh.com
ISIN: CH0126673539
Valor: 12667353
Listed: SIX Swiss Exchange
EQS News ID: 2246914

 
End of News EQS News Service

2246914  17.12.2025 CET/CEST

Kommentare (0) ... diskutiere mit.
Werbung

Handeln Sie Aktien bei SMARTBROKER+ für 0 Euro!* Profitieren Sie von kostenloser Depotführung, Zugriff auf 29 deutsche und internationale Börsenplätze und unschlagbar günstigen Konditionen – alles in einer innovativen, brandneuen App. Jetzt zu SMARTBROKER+ wechseln und durchstarten!

*Ab 500 EUR Ordervolumen über gettex. Zzgl. marktüblicher Spreads und Zuwendungen.

Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer